BUSINESS● LOWSep 17 · Sep 17, 2026, 4:06 PM
BioCryst (BCRX) Turns its First Profit and Now Wants to Go Shopping for Rare Disease Drugs
Yahoo Finance · global
BioCryst has reported its first profit and plans to acquire rare disease drugs. This marks a significant financial milestone and strategic shift for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowHas Bola Tinubu succeeded in getting the Nigerian economy up and running?Jeune AfriqueBUSINESS12m agoTotalEnergies acquires 25% stake in 26 Chevron U.S. offshore leasesSeeking Alpha Tech